| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 3 | +33.33% | -3.59% | -1.58% | -2.01% | +2.00% | — |
| 14d | 3 | +0.00% | -9.79% | +1.01% | -10.81% | -5.97% | — |
| 30d | 3 | +33.33% | -3.59% | +1.53% | -5.12% | -10.91% | — |
| 60d | 3 | +66.67% | +11.19% | +4.48% | +6.70% | +0.15% | — |
| 90d | 3 | +33.33% | +16.25% | +5.87% | +10.38% | -1.98% | — |
| 180d | 3 | +66.67% | +3.64% | +10.33% | -6.68% | -16.43% | — |
| 1y | 3 | +33.33% | -22.69% | +17.95% | -40.64% | -23.78% | — |
| 2y | 3(1 pending) | +100.00% | +48.08% | +46.27% | +1.81% | +1.81% | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| HUMA HUMACYTE, INC. | PURCHASE Chief Commercial Officer | 6,493 | $1.54 | $10.0K | 22,018 | Apr 14, 2025 | Apr 15, 2025 ↗ | View → |
| HUMA HUMACYTE, INC. | PURCHASEGRANT Stock grant | 283,101 | — | — | 283,101 | Jan 21, 2025 | Jan 23, 2025 ↗ | View → |
| HUMA HUMACYTE, INC. | PURCHASEGRANT Stock grant | 276,000 | — | — | 276,000 | Dec 8, 2023 | Dec 12, 2023 ↗ | View → |
| HUMA HUMACYTE, INC. | PURCHASE Chief Commercial Officer | 5,000 | $3.09 | $15.4K | 15,525 | Dec 13, 2022 | Dec 15, 2022 ↗ | View → |
| HUMA HUMACYTE, INC. | PURCHASEGRANT Stock grant | 136,000 | — | — | 136,000 | Dec 8, 2022 | Dec 12, 2022 ↗ | View → |
| HUMA HUMACYTE, INC. | PURCHASE Chief Commercial Officer | 10,525 | $4.72 | $49.7K | 10,525 | May 24, 2022 | May 25, 2022 ↗ | View → |
| HUMA HUMACYTE, INC. | PURCHASEGRANT Stock grant | 157,558 | — | — | 157,558 | Oct 13, 2021 | Oct 15, 2021 ↗ | View → |